Planta Med 2003; 69(12): 1150-1152
DOI: 10.1055/s-2003-818008
Letter
© Georg Thieme Verlag Stuttgart · New York

Demethylbellidifolin Inhibits Adhesion of Monocytes to Endothelial Cells via Reduction of Tumor Necrosis Factor alpha and Endogenous Nitric Oxide Synthase Inhibitor Level

De-Jian Jiang1 , Jun-Lin Jiang1 , Gui-Shan Tan2 , Zhi-Zhuang Huang1 , Han-Wu Deng1 , Yuan-Jian Li1
  • 1Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, China
  • 2Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Central South University, Changsha, China
This study was supported by a grant from the Provincial Natural Science Foundation of Hunan, China, No. 02jjy2046
Further Information

Publication History

Received: May 7, 2003

Accepted: August 30, 2003

Publication Date:
29 January 2004 (online)

Zoom Image

Abstract

The effect of demethylbellidifolin (DMB), a major compound of Swertia davidi Franch, on the adhesion of monocytes to endothelial cells induced by oxidized low-density lipoprotein (ox-LDL) was studied. Adhesion of monocytes to endothelial cells was induced by treatment with ox-LDL (100 μg/mL) for 48 h. Levels of tumor necrosis factor-α (TNF-α) and asymmetric dimethylarginine (ADMA, an endogenous inhibitor of NOS) in conditioned medium and the activity of dimethylarginine dimethylaminohydrolase (DDAH) in endothelial cells were measured. DMB (3 or 10 μmol/L) significantly inhibited the adhesion of monocytes to endothelial cells, attenuated an increase in levels of TNF-α and ADMA, and a decrease in the activity of DDAH by ox-LDL. The present results suggest that DMB inhibits the increased adhesion of monocytes to endothelial cells induced by ox-LDL, and that the effect of DMB is related to reduction of the ADMA concentration via reduction of TNF-α  production in cultured endothelial cells treated with ox-LDL.